Also known as Novolin GE NPH (in Canada)
Novolin N is a intermediate-acting insulin and a recombinant insulin that functions as an exact copy of the insulin produced naturally by the human body. Novolin N can be used for treatment of both Type 1 and Type 2 diabetes, and as an intermediate-acting insulin it provides more gradual and extended blood glucose control for patients who don’t have high blood sugar spikes as much as having their levels stay elevated longer term after eating. Insulin human works by moving glucose out of the bloodstream and into cells to lower the blood sugar levels, and dose titration and sliding scale dosing are quite common with this insulin.
Standard dosage guidelines for Novolin N is to administer injection 30 minutes before each meal of the day.
Injection may be administered into one of 4 acceptable injection sites: abdomen (excluding a 2” radius around navel) / back of upper arm / buttocks / thighs.
Choose a different injection site for every new injection. Injection at the same injection site consecutively increases the risk of lipodystrophy.
Wash your hands.
Prepare syringe for injection, including attaching needle if required depending on the type of syringe you are using.
Insert needle tip through vial covering and into Novolin NPH insulin solution and pull back on plunger handle to fill syringe with insulin, measuring correct amount by looking at measurement points on the syringe.
Once syringe is filled to the correct amount, remove the needle from the vial and keep needle in upright position and firmly in hand as you prepare to administer the injection.
Administer Novolin NPH injection in one the three spots listed above.
The needle should stay in your skin for at least 5 seconds to make sure you have injected all of your insulin dose.
The active ingredients in Novolin N is Insulin Human.
Tell your doctor if you have any history of heart failure, kidney or liver problems, low blood sugar (hypoglycemia), low potassium levels (hypokalemia), or allergic reactions before starting on Novolin N insulin.
Medication is not recommended for the treatment of diabetic ketoacidosis.
Keep Novolin N insulin stored at 36°F to 46°F (2°C to 8°C) or at room temperature below 86°F (30°C) as indicated in your medication. Keep opened Novolin N vials stored at a temperature less than 77°F (25°C), but any unused vials must be discarded after 42 days.
There is the possibility of negative drug interactions between Novolin N and other Rx medications, including glyburide / glimepiride / lisinopril / enalapril / benazepril / irbesartan / olmesartan / losartan / valsartan / gemfibrozil / fenofibrate / fluoxetine (Prozac) / phenelzine / tranylcypromine / selegiline / disopyramide / pentoxifylline / octreotide / olanzapine / clozapine.
Tell your doctor of all medications you are taking before receiving a medication and proceeding to buy Novolin N insulin from Canada.
Novolin N side effects are possible, and some users may have injection site skin irritation, lipodystrophy, weight gain, headache, or edema (swelling in feet and / or ankles). If these side effects are experienced you may want to discontinue use and speak to your doctor again about insulin vial alternatives to Novolin N for Type 1 and Type 2 diabetes treatment.
